FLERIE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - InDex Pharmaceuticals Holding AB

Watchlist Manager

Watchlist

Price: 20.2 SEK 1.76% Market Closed

Market Cap: kr1.9B

I	InDex Pharmaceuticals Holding AB STO:FLERIE	SE
	Valiant Holding AG F:VAT	CH
B	Boyd Gaming Corp DUS:BO5	US
	Christian Dior SE XETRA:DIO	FR
	Parkmead Group PLC LSE:PMG	UK
	Perion Network Ltd NASDAQ:PERI	IL
	NETGEAR Inc NASDAQ:NTGR	US
	Edgewell Personal Care Co NYSE:EPC	US
D	Discovery Ltd JSE:DSY	ZA
	OUTFRONT Media Inc NYSE:OUT	US
	Longfor Group Holdings Ltd HKEX:960	CN
	360 DigiTech Inc NASDAQ:QFIN	CN

Profitability Summary

InDex Pharmaceuticals Holding AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Negative 3Y Average Gross Margin

-32 431%

Low Operating Margin

Negative 3Y Average Operating Margin

-82 506%

Low Net Margin

Negative 3Y Average Net Margin

-127 204%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-25 479%

Negative ROE

-20%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

691%

Declining ROIC

371% > -1%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.